English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Hemipelvectomy Resection large tumor size which is undetectable at the early-onset and local complex anatomy with the severe extension to major neurovascular structures and intestinal and urinary tracts. Traditionally, malignant pelvic bone tumors were resected by the hindquarter amputation and the procedure obviously influenced the detrimental cosmetic and physical outcomes. More attempts have been made to perform the limb-salvage and improve the reconstruction of the pelvis after tumor resection. However, the abundant clinical experience could not be accumulated at the single tumor center due to the low incidence of pelvic bone tumors. Furthermore, the poor prognosis previously occurred to patients with tumors due to the anatomic complexity and scanty clinical experience. With the development of surgical skills and related discipline, many hospitals, especially Musculoskeletal Tumor Center of Peking University People’s Hospital (PKUPH), gathered a great deal of surgical experience of resecting themalignant pelvic tumors in the past two decades in China. The overall survival and limb-salvage rates and lower extremity function were significantly improved by more effects of many orthopedic oncologists in China in the past years. The present article was to review the limb-salvage surgery for the malignant pelvic tumors in the past two decades.

Limb-salvage treatment of malignant pelvic bone tumor in China for past 20 years